We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2014 by Karl-Michael Schebesch, University of Regensburg.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01292278
First Posted: February 9, 2011
Last Update Posted: December 5, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Technische Universität München
Information provided by (Responsible Party):
Karl-Michael Schebesch, University of Regensburg
February 8, 2011
February 9, 2011
December 5, 2014
January 2006
August 2015   (Final data collection date for primary outcome measure)
Glasgow Outcome Scale [ Time Frame: 2011-2016 ]
Not Provided
Complete list of historical versions of study NCT01292278 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients
The Possible Role of Neuropeptide Y After Spontaneous Subarachnoid Hemorrhage
Neuropeptide Y (NPY) may play a major role in the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH). To investigate the correlation of NPY in cerebrospinal fluid (CSF) and blood (serum) and the neurological outcome in the acute stage of aSAH.
Evaluation of Neuropeptides in CSF and serum in SAH patients
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
cerebrospinal fluid / serum
Probability Sample
consecutive pts. with subarachnoid hemorrhage
Subarachnoid Hemorrhage
Not Provided
  • aSAH
    consecutive patients with spontaneous or aneurysmal subarachnoid hemorrhage
  • control group
    no neurological disease but spinal anesthesia
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
90
December 2016
August 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • spontaneous or aneurysmal subarachnoid hemorrhage

Exclusion Criteria:

  • age younger than 18 years or older than 70 years
  • inflammatory disease
  • history of former SAH
  • no ventricular drainage
Sexes Eligible for Study: All
18 Years to 70 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT01292278
CSF 06/179
Yes
Not Provided
Not Provided
Karl-Michael Schebesch, University of Regensburg
University of Regensburg
Technische Universität München
Not Provided
University of Regensburg
December 2014